Research programme: companion diagnostics - cancer - ImmunoGen/Ventana Medical Systems
Latest Information Update: 31 Oct 2014
At a glance
- Originator ImmunoGen; Ventana Medical Systems
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 28 Oct 2014 Preclinical studies in Cancer (Diagnosis) in USA (unspecified route)